Sanofi-A Ventis Deutschland Gmbh

Zhaoxia Yang

Siegfried Stengelin

Kenneth J Bordeau

Matthias Gossel

Thomas Klabunde

Gregory H Merriman

Martin Smrcina

Brian K Whiteley

Pavel Safar

Carolina Lanter

James Spoonamore

Joseph T Klein

Stefanie Flohr

Petra Lennig

Petra Stahl

The invention relates to substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives substituted with amino acids, and to the physiologically tolerated salts thereof, processes for their preparation and their use as medicaments.

Hexahydro-pyrazino[1,2-A]pyrimidine-4,7-dione derivatives substituted with amino acids

Nitrogen-substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, processes for the preparation and their use as medicaments The invention relates to substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof. Compounds of the formula I in which the radicals have the stated meanings, and the physiologically tolerated salts thereof and processes for preparing them are described. The compounds are suitable for example as anorectic agents.

Nitrogen-substituted hexahydropyrazino[1,2-A]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments

Growing community of inventors

Roselle Park, NJ, United States of America

Zhaoxia Yang